Retina/Vitreous

Top Story

Ocugen gene therapy receives orphan drug designation

September 18, 2019

Xephilio OCT-A1 receives 510(k) clearance

September 17, 2019
The FDA has granted 510(k) clearance to Canon U.S.A.’s Xephilio OCT-A1 OCT device, according to a press release. Together with the RX Capture software, computer…

Augmented reality visual aids may improve mobility in RP patients

September 13, 2019
Use of augmented reality low-vision aids for patients with retinitis pigmentosa may assist with mobility and grasp, a recent study suggests. “When exposed to our…

Better anatomical improvements seen with OPT-302 with ranibizumab vs. ranibizumab alone

September 13, 2019
Patients treated with OPT-302 from Opthea Limited plus ranibizumab demonstrated better anatomical changes over those treated with ranibizumab alone in a phase 2b study…
More Headlines »
CME

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

The treatment of neovascular age-related macular degeneration (nAMD) has been revolutionized through the introduction…
More »
Video
Meeting News

VIDEO: Study quantifies benefit of sustained-release implant in DME

August 3, 2019
More »
Video
Meeting News

VIDEO: Steroid challenge predictive of IOP lowering in eyes with fluocinolone implants

August 16, 2019
More »